{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:41:11Z","timestamp":1793659271981,"version":"4.5.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1995,8]]},"DOI":"10.1212\/wnl.45.8.1488","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:17:07Z","timestamp":1336915027000},"page":"1488-1493","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":498,"title":["The Warfarin-Aspirin Symptomatic Intracranial Disease Study"],"prefix":"10.1212","volume":"45","author":[{"given":"M.I.","family":"Chimowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kokkinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. B.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Silliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Pessin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Weichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Sila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. E.","family":"Kargman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. L.","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Wityk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. B.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Warfarin-Aspirin Symptomatic Intracranial Disease Study Group*","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.26.1.1"},{"key":"e_1_3_1_3_2","first-page":"5","volume":"299","year":"1978","unstructured":"The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978;299:53-58.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_4_2","first-page":"1","volume":"2","year":"1987","unstructured":"The ESPS Group. The European Stroke Prevention Study (ESPS): principal end-points. Lancet 1987;2:1351-1354.","journal-title":"Lancet"},{"key":"e_1_3_1_5_2","first-page":"3","volume":"296","year":"1988","unstructured":"Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988;296:320-331.","journal-title":"BMJ"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198507043130101"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.17.1.1"},{"key":"e_1_3_1_8_2","first-page":"6","volume":"58","year":"1963","unstructured":"Siekert RG, Whisnant JP, Millikan CH. Surgical and anticoagulant therapy of occlusive cerebrovascular disease. Ann Intern Med 1963;58:637-641.","journal-title":"Ann Intern Med"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.12.1.8"},{"key":"e_1_3_1_10_2","first-page":"5","volume":"12","year":"1981","unstructured":"Buren A, Ygge J. Treatment program and comparison between anticoagulants and platelet aggregation inhibitors after transient ischemic attack. Stroke 1981;12:578-580.","journal-title":"Stroke"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.11.1.4"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410030102"},{"key":"e_1_3_1_13_2","first-page":"8","volume":"21","year":"1990","unstructured":"Estol CJ, Pessin MS. Anticoagulation: is there still a role in atherothrombotic stroke? Stroke 1990;21:820-824.","journal-title":"Anticoagulation: is there still a role in atherothrombotic stroke? Stroke"},{"key":"e_1_3_1_14_2","first-page":"4","volume":"325","year":"1991","unstructured":"North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_15_2","first-page":"6","volume":"53","year":"1978","unstructured":"Sandok BA, Furlan AJ, Whisnant JP, Sundt TM. Guidelines for the management of transient ischemic attacks. Mayo Clin Proc 1978;53:665-674.","journal-title":"Mayo Clin Proc"},{"key":"e_1_3_1_16_2","first-page":"7","volume":"17","year":"1986","unstructured":"Wechsler LR, Kistler JP, Davis KR, Kaminski MJ. The prognosis of carotid siphon stenosis. Stroke 1986;17:714-718.","journal-title":"Stroke"},{"key":"e_1_3_1_17_2","first-page":"8","volume":"13","year":"1982","unstructured":"Craig DR, Meguro K, Watridge C, Robertson JT, Barnett HJM, Fox AJ. Intracranial internal carotid artery stenosis. Stroke 1982;13:825-828.","journal-title":"Stroke"},{"key":"e_1_3_1_18_2","first-page":"8","volume":"13","year":"1982","unstructured":"Marzewski DJ, Furlan AJ, St Louis P, Little JR, Modic MT, Williams G. Intracranial internal carotid artery stenosis: long-term prognosis. Stroke 1982;13:821-824.","journal-title":"Stroke"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410050102"},{"key":"e_1_3_1_20_2","first-page":"9","volume":"35","year":"1985","unstructured":"Caplan L, Babikian V, Helgason C, et al. Occlusive disease of the middle cerebral artery. Neurology 1985;35:975-982.","journal-title":"Neurology"},{"key":"e_1_3_1_21_2","first-page":"9","volume":"17","year":"1986","unstructured":"Moufarrij NA, Little JR, Furlan AJ, Leatherman JR, Williams GW. Basilar and distal vertebral artery stenosis: long-term follow-up. Stroke 1986;17:938-942.","journal-title":"Stroke"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.1.1"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360103"},{"key":"e_1_3_1_24_2","first-page":"5","volume":"30","year":"1991","unstructured":"Albers GW, Sherman DG, Gress DR, Paulseth JE, Petersen P. Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials. Ann Neurol 1991;30:511-518.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","unstructured":"Dyken ML Barnett HJ Easton JD et al. Low-dose aspirin and stroke. `It ain't necessarily so.' Stroke 1992;23:1395-1399.","DOI":"10.1161\/01.STR.23.10.1395"},{"key":"e_1_3_1_26_2","first-page":"5","volume":"321","year":"1989","unstructured":"Hass WK, Easton JD, Adams HP Jr, et al, for the Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321:501-507.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_27_2","first-page":"1","volume":"42","year":"1992","unstructured":"Grotta JC, Norris JW, Kamm B, TASS Baseline and Angiographic Data Subgroup. Prevention of stroke with ticlopidine: who benefits most? Neurology 1992;42:111-115.","journal-title":"Prevention of stroke with ticlopidine: who benefits most? Neurology"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.45.8.1488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:16:08Z","timestamp":1711642568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.45.8.1488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1995,8]]}},"alternative-id":["10.1212\/WNL.45.8.1488"],"URL":"https:\/\/doi.org\/10.1212\/wnl.45.8.1488","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,8]]}}}